Evidence map›Paper›PMID 30386444›Full record

ArticleHereditary cancer in clinical practice2018

A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families.

Masoud Karimi, Jenny von Salomé, Christos Aravidis, Gustav Silander, Marie Stenmark Askmalm, Isabelle Henriksson, Samuel Gebre-Medhin, Jan-Erik Frödin, Erik Björck, Kristina Lagerstedt-Robinson and 2 more

Open access · goldAbstract read
In one paragraph

Article in Hereditary cancer in clinical practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Genetic Gastric Cancer Risk Syndromes.Current treatment options in gastroenterology · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Masoud Karimi1Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Jenny von Salomé2Department of Clinical Genetics, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.
Christos Aravidis4Department of Clinical Genetics, Akademiska University Hospital, Uppsala, Sweden.
Gustav Silander5Department of Clinical Genetics, Norrlands University Hospital, Umeå, Sweden.
Marie Stenmark Askmalm6Department of Clinical Genetics, Linköpings University Hospital, Linköping, Sweden.
Isabelle Henriksson7Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Samuel Gebre-Medhin7Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Jan-Erik Frödin1Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Erik Björck2Department of Clinical Genetics, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.
Kristina Lagerstedt-Robinson2Department of Clinical Genetics, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.
Annika Lindblom2Department of Clinical Genetics, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.
Emma Tham2Department of Clinical Genetics, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.ORCID 0000-0001-6079-164X
Karolinska University Hospital · SELund University · SEUniversity Hospital of Umeå · SEUppsala University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLynch Syndrome is an autosomal dominant cancer syndrome caused by pathogenic germ-line variants in one of the DNA-mismatch-repair (MMR) genes

methodsData were obtained from genetically verified 235 Lynch families from five of the six health care regions in Sweden. The material was stratified for gender, primary cancer, age and mutated gene and the relative proportions of specific cancer types were compared to those in the general population.

resultsA total of 1053 family members had 1493 cancer diagnoses of which 1011 were colorectal or endometrial cancer. Individuals with pathogenic variants in

conclusionLynch syndrome confers an increased risk for multiple cancers other than colorectal and endometrial cancer. The proportions of other cancers vary between different MMR genes, with highest frequency in

Indexed as

ExtracolonicLynch syndromeMMR genesTumour spectrum

Identifiers

PMID30386444
PMCPMC6199799
OpenAlexW2896499749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.